Skip to content
  • Wednesday, 28 October 2026
  • 1:20 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s.
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s.

Lana Keisha Jun 22, 2026 0

A significant stride in the realm of integrated medicine has been reported by Remepy, a pioneering startup, as its innovative…

Read More
Laboratory Automation & Robotics

Beyond PD-1: The Drugs Reshaping Cancer Treatment at ASCO 2026

Lana Keisha Jun 17, 2026 0

The biomedical sector is once again experiencing a vibrant resurgence, marked by robust investment, strategic mergers and acquisitions (M&A), and…

Read More
Laboratory Automation & Robotics

How CTF is trying to rescue pharma’s shelved rare disease drugs

Lana Keisha Jun 15, 2026 0

Across the global pharmaceutical landscape, a staggering number of potentially life-changing therapies for rare diseases lie dormant, gathering dust on…

Read More
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

Lana Keisha Jun 15, 2026 0

In a significant advancement for integrated medicine, Remepy, a pioneering startup, has announced successful Phase IIa clinical trial results for…

Read More
Laboratory Automation & Robotics

How CTF is trying to rescue pharma’s shelved rare disease drugs

Lana Keisha Jun 6, 2026 0

More than 5,000 potentially life-changing treatments for rare diseases are currently languishing on pharmaceutical company shelves, representing a vast reservoir…

Read More
Laboratory Automation & Robotics

Beyond PD-1: The drugs reshaping cancer treatment at ASCO 2026

Lana Keisha Jun 4, 2026 0

The biotechnology sector, a critical engine of medical innovation, is experiencing a robust resurgence, marking a significant turnaround from recent…

Read More
Laboratory Automation & Robotics

Beyond PD-1: The drugs reshaping cancer treatment at ASCO 2026

Lana Keisha May 28, 2026 0

The biotechnology sector is experiencing a significant resurgence, marked by a robust recovery in public markets and an explosion in…

Read More
Laboratory Automation & Robotics

Pharma 50: The 50 best-selling drugs of FY2025

Lana Keisha May 25, 2026 0

The fiscal year 2025 closed with a dramatic reshuffling at the pinnacle of the pharmaceutical industry’s sales leaderboard, signaling profound…

Read More
Laboratory Automation & Robotics

How to tackle the unique pharmacokinetic properties of covalent drugs

Lana Keisha May 18, 2026 0

Covalent drugs, a class of therapeutics that form irreversible or quasi-irreversible bonds with their biological targets, have undergone a remarkable…

Read More
Laboratory Automation & Robotics

Pharma 50: The 50 best-selling drugs of FY2025

Lana Keisha May 17, 2026 0

The fiscal year 2025 concluded with a dramatic reshuffling at the pinnacle of the pharmaceutical industry’s sales leaderboard, signaling profound…

Read More

Posts pagination

1 2 3 4 … 6
Yale Research Team Deciphers Molecular Mechanism Blocking Fertilization Paving the Way for New Contraceptive and Infertility TreatmentsThe Non-GLP-1 Obesity Drug Market Set for Explosive 50-Fold Growth, Reaching $15.5 Billion by 2031Science News: A Century of Empowering Public Understanding of ScienceResonant Mie Voids in Bismuth Telluride Enhance Light Emission and Nonlinear Optical Responses in Atomically Thin Tungsten Disulfide
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
The oral exposure challenge in PROTACs: What drug developers need to solve earlyThe Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALSESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial CancerThe Discovery of REM-like Sleep in Jumping Spiders Challenges Traditional Views of Animal Consciousness
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Oct 28, 2026
Environmental & Analytical Chemistry
The Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALS
Abdurrohim Arsyad Oct 28, 2026
Pharmaceutical R&D
ESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial Cancer
Teuku Ryan Oct 28, 2026
Molecular & Cell Biology
The Discovery of REM-like Sleep in Jumping Spiders Challenges Traditional Views of Animal Consciousness
Angie Faith Oct 28, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ